Status:
COMPLETED
Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate
Lead Sponsor:
British Columbia Cancer Agency
Collaborating Sponsors:
Biocompatibles UK Ltd
Conditions:
Prostate Cancer
Eligibility:
MALE
40-80 years
Phase:
PHASE3
Brief Summary
This study compares the ability of a new design of brachytherapy seed for prostate seed implants for treatment of prostate cancer to maintain their intended position in the prostate after being deposi...
Detailed Description
Standard post implant prostate brachytherapy quality assurance at the Center for the Southern Interior is usually performed at one month after the procedure with CT and MR imaging. In order to test th...
Eligibility Criteria
Inclusion
- localized prostate cancer
- favorable or intermediate risk
- suitable for permanent seed implant by functional and technical criteria
Exclusion
- patient unwilling to have a second CT scan for study purposes
- claustrophobic patient unable to have CT scan
- patient unsuitable for brachytherapy because of prostate size or poor voiding function
- patient medically unable to stop anticoagulants for procedure
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT01174017
Start Date
September 1 2010
End Date
December 1 2011
Last Update
February 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Center for the Southern Interior
Kelowna, British Columbia, Canada, V1Y 5L3